CCD-1095Sk Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Skin cancer cell lines |
| Organism |
Human |
| Donor History |
Ductal carcinoma |
| Growth Properties |
Adherent |
| Growth Conditions |
Culture medium: EMEM (MEM Eagle) ,w: 2 mM L-Glutamine ,w: 2.2 g/L NaHCO3 ,w: EBSS (Cytion article number 820100a). Supplements: Supplement the medium with 10% FBS and 1% NEAA. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
CCD-1095Sk is a fibroblast cell line derived from the skin of a human male. It was established from a biopsy of uninvolved skin taken from a patient who had a squamous cell carcinoma. This cell line is utilized primarily in studies that explore the interactions between skin cells and cancerous cells, particularly how non-cancerous cells in the tumor microenvironment can influence tumor growth and progression. The CCD-1095Sk cell line is therefore valuable for cancer research, specifically for understanding the stromal aspects of skin cancer.
The CCD-1095Sk cells exhibit a fibroblast morphology, characterized by a spindle-shaped, elongated form typical of connective tissue cells that produce extracellular matrix components essential for tissue repair and structural integrity. These cells are adherent, grow in monolayers, and are known for their robustness in various in vitro experimental conditions. They are used to model fibroblast behavior in normal skin and to examine changes in fibroblast activity under cancerous conditions, which can include the secretion of growth factors, cytokines, and matrix metalloproteinases. As such, they provide an invaluable tool for pharmacological studies and the development of therapeutic strategies targeting the tumor environment.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

